Elevated asleep blood pressure and non-dipper 24h patterning best predict risk for heart failure that can be averted by bedtime hypertension chronotherapy: A review of the published literature

References

• Agarwal SK, Chambless LE, Ballantyne CM, Astor B, Bertoni AG, Chang PP, Folsom AR, He M, Hoogeveen RC, Ni H, et al. 2012. Prediction of incident heart failure in general practice: the Atherosclerosis Risk in Communities (ARIC) Study. Circ Heart Fail. 5(4):422–429. doi:10.1161/CIRCHEARTFAILURE.111.964841
   PubMed Web of Science ®Google Scholar
• Ambrosy AP, Fonarow GC, Butler J, Chioncel O, Greene SJ, Vaduganathan M, Nodari S, Lam CSP, Sato N, Shah AN, et al. 2014. The global health and economic burden of hospitalizations for heart failure. J Am Coll Cardiol. 63(12):1123–1133. doi:10.1016/j.jacc.2013.11.053
   PubMed Web of Science ®Google Scholar
• Ayala DE, Hermida RC, Mojón A, Fernández JR. 2013b. Cardiovascular risk of resistant hypertension: dependence on treatment-time regimen of blood pressure–lowering medications. Chronobiol Int. 30(1–2):340–352. doi:10.3109/07420528.2012.701455
   PubMed Web of Science ®Google Scholar
• Ayala DE, Moyá A, Crespo JJ, Castiñeira C, Domínguez-Sardiña M, Gomara S, Sineiro E, Mojón A, Fontao MJ, Hermida RC, on behalf of the Hygia Project Investigators. 2013c. Circadian pattern of ambulatory blood pressure in hypertensive patients with and without type 2 diabetes. Chronobiol Int. 30(1–2):99–115. doi:10.3109/07420528.2012.701489
   PubMed Web of Science ®Google Scholar
• Baraldo M. 2008. The influence of circadian rhythms on the kinetics of drugs in humans. Expert Opin Drug Metab Toxicol. 4(2):175–192. doi:10.1517/17425255.4.2.175
   PubMed Web of Science ®Google Scholar
• Bélanger PM, Bruguerolle B, Labrecque G. 1997. Rhythms in pharmacokinetics: absorption, distribution, metabolism, and excretion. In: Redfern PH, Lemmer B, editors. Physiology and Pharmacology of Biological Rhythms. Handbook of Experimental Pharmacology series (Vol. 125). Berlin-New York: Springer-Verlag; p. 177–204.
   Google Scholar
• Ben-Dov IZ, Kark JD, Ben-Ishay D, Mekler J, Ben-Arie L, Bursztyn M. 2007. Predictors of all-cause mortality in clinical ambulatory monitoring. Unique aspects of blood pressure during sleep. Hypertension 49:1235–1241. doi:10.1161/HYPERTENSIONAHA.107.087262
   PubMed Web of Science ®Google Scholar
• Black HR, Elliott WJ, Grandits G, Grambsch P, Lucente T, White WB, Neaton JD, Grimm RH Jr, Hansson L, Lacourciere Y, et al. 2003. Principal results of the Controlled Onset Verapamil Investigation of Cardiovascular End Points (CONVINCE) trial. JAMA. 289(16):2073–2082. doi:10.1001/jama.289.16.2073
   PubMed Web of Science ®Google Scholar
• Bowles NP, Thosar SS, Herzig MX, Shea SA. 2018. Chronotherapy for hypertension. Curr Hypertens Rep. 20:97. doi:10.1007/s11906-018-0897-4
   PubMed Web of Science ®Google Scholar
• Brotman DJ, Davidson MB, Boumitri M, Vidt DG. 2008. Impaired diurnal blood pressure variation and all-cause mortality. Am J Hypertens. 21:92–97. doi:10.1038/ajh.2007.7
   PubMed Web of Science ®Google Scholar
• Bruguerolle B. 1998. Chronopharmacokinetics Current status. Clin Pharmacokinet 35:83–94. doi:10.2165/00003088-199835020-00001
   PubMed Web of Science ®Google Scholar
• Butler J, Kalogeropoulos A, Georgiopoulou V, Belue R, Rodondi N, Garcia M, Bauer DC, Satterfield S, Smith AL, Vaccarino V, et al. 2008. Incident heart failure prediction in the elderly: the health ABC heart failure score. Circ Heart Fail. 1:125–133.
   PubMed Web of Science ®Google Scholar
• Caruana MP, Lahiri A, Cashman PMM, Altman DG, Raftery EB. 1988. Effects of chronic congestive heart failure secondary to coronary artery disease on the circadian rhythm of blood pressure and heart rate. Am J Cardiol. 62:755–759. doi:10.1016/0002-9149(88)91217-9
   PubMed Web of Science ®Google Scholar
• De Giorgi A, Menegatti AM, Fabbian F, Portaluppi F, Manfredini R. 2013. Circadian rhythms and medical diseases: does it matter when drugs are taken? Eur J Intern Med. 24:698–706. doi:10.1016/j.ejim.2013.03.019
   PubMed Web of Science ®Google Scholar
• Dolan E, Stanton A, Thijs L, Hinedi K, Atkins N, McClory S, Den Hond E, McCormack P, Staessen JA, O’Brien E. 2005. Superiority of ambulatory over clinic blood pressure measurement in predicting mortality: the Dublin outcome study. Hypertension. 46:156–161. doi:10.1161/01.HYP.0000170138.56903.7a
   PubMed Web of Science ®Google Scholar
• Fabbian F, Smolensky MH, Tiseo R, Pala M, Manfredini R, Portaluppi F. 2013. Dipper and non-dipper blood pressure 24-hour patterns: circadian rhythm-dependent physiologic and pathophysiologic mechanisms. Chronobiol Int. 30:17–30. doi:10.3109/07420528.2012.715872
   PubMed Web of Science ®Google Scholar
• Fagard RH, Celis H, Thijs L, Staessen JA, Clement DL, De Buyzere ML, De Bacquer DA. 2008. Daytime and nighttime blood pressure as predictors of death and cause-specific cardiovascular events in hypertension. Hypertension. 51:55–61. doi:10.1161/HYPERTENSIONAHA.107.100727
   PubMed Web of Science ®Google Scholar
• Fan HQ, Li Y, Thijs L, Hansen TW, Boggia J, Kikuya M, Björklund-Bodegard K, Richart T, Ohkubo T, Jeppesen J, et al. 2010. Prognostic value of isolated nocturnal hypertension on ambulatory measurement in 8711 individuals from 10 populations. J Hypertens. 28:2036–2045. doi:10.1097/HJH.ob013e32833b49fe
   PubMed Web of Science ®Google Scholar
• Goyal D, Macfadyen RJ, Watson RD, Lip GYH. 2005. Ambulatory blood pressure monitoring in heart failure: a systematic review. Eur J Heart Fail. 7:149–156. doi:10.1016/j.ejheartf.2004.05.010
   PubMed Web of Science ®Google Scholar
• Gupta R, Malik AH, Popli T, Ranchal P, Yandrapalli S, Aronow WS. 2020. Impact of bedtime dosing of antihypertensives compared to morning therapy: a meta-analysis of randomised controlled trials. Eur J Prev Cardiol. doi:10.1177/2047487320903611
   PubMed Web of Science ®Google Scholar
• Hammond G, Rich MW. 2019. Hypertensive heart failure in the very old. Heart Fail Clin. 15:477–485. doi:10.1016/j.hfc.2019.06.001
   PubMed Web of Science ®Google Scholar
• Hermida RC, Ayala DE, Fontao MJ, Mojón A, Fernández JR. 2013a. Ambulatory blood pressure monitoring: importance of sampling rate and duration – 48 versus 24 hours – on the accurate assessment of cardiovascular risk. Chronobiol Int. 30:55–67. doi:10.3109/07420528.2012.701457
   PubMed Web of Science ®Google Scholar
• Hermida RC, Ayala DE, Mojon A, Fernandez JR. 2008. Chronotherapy with nifedipine GITS in hypertensive patients: improved efficacy and safety with bedtime dosing. Am J Hypertens. 21:948–954. doi:10.1038/ajh.2008.216
   PubMed Web of Science ®Google Scholar
• Hermida RC, Ayala DE, Mojón A, Fernández JR. 2010. Influence of circadian time of hypertension treatment on cardiovascular risk: results of the MAPEC study. Chronobiol Int. 27:1629–1651. doi:10.3109/07420528.2010.510230
   PubMed Web of Science ®Google Scholar
• Hermida RC, Ayala DE, Mojón A, Fernández JR. 2011a. Decreasing sleep-time blood pressure determined by ambulatory monitoring reduces cardiovascular risk. J Am Coll Cardiol. 58:1165–1173. doi:10.1016/j.jacc.2011.04.043
   PubMed Web of Science ®Google Scholar
• Hermida RC, Ayala DE, Mojón A, Fernández JR. 2011b. Influence of time of day of blood pressure-lowering treatment on cardiovascular risk in hypertensive patients with type 2 diabetes. Diabetes Care. 34:1270–1276. doi:10.2337/dc11-0297/-/DC1
   PubMed Web of Science ®Google Scholar
• Hermida RC, Ayala DE, Mojón A, Fernández JR. 2011c. Bedtime dosing of antihypertensive medications reduces cardiovascular risk in CKD. J Am Soc Nephrol. 22:2313–2321. doi:10.1681/ASN.2011040361
   PubMed Web of Science ®Google Scholar
• Hermida RC, Ayala DE, Mojón A, Fernández JR. 2012. Sleep-time blood pressure and the prognostic value of isolated-office and masked hypertension. Am J Hypertens. 25:297–305. doi:10.1038/ajh.2011.208
   PubMed Web of Science ®Google Scholar
• Hermida RC, Ayala DE, Mojón A, Fernández JR. 2013b. Cardiovascular risk of essential hypertension: influence of class, number, and treatment-time regimen of hypertension medications. Chronobiol Int. 30:315–327. doi:10.3109/07420528.2012.701534
   PubMed Web of Science ®Google Scholar
• Hermida RC, Ayala DE, Smolensky MH, Fernández JR, Mojón A, Portaluppi F. 2016. Chronotherapy with conventional blood pressure medications improves management of hypertension and reduces cardiovascular and stroke risks. Hypertens Res. 39:277–292. doi:10.1007/s00125-015-3748-8
   PubMed Web of Science ®Google Scholar
• Hermida RC, Ayala DE, Smolensky MH, Fernández JR, Mojón A, Portaluppi F. 2017. Sleep-time blood pressure: unique sensitive prognostic marker of vascular risk and therapeutic target for prevention. Sleep Med Rev. 33:17–27. doi:10.1016/j.smrv.2016.04.001
   PubMed Web of Science ®Google Scholar
• Hermida RC, Calvo C, Ayala DE, Lopez JE, Rodriguez M, Chayan L, Mojon A, Fontao MJ, Fernandez JR. 2007. Dose- and administration-time-dependent effects of nifedipine GITS on ambulatory blood pressure in hypertensive subjects. Chronobiol Int. 24:471–493. doi:10.1080/07420520701420683
   PubMed Web of Science ®Google Scholar
• Hermida RC, Calvo C, Ayala DE, Mojón A, López JE. 2002. Relationship between physical activity and blood pressure in dipper and nondipper hypertensive patients. J Hypertens. 20:1097–1104. doi:10.1097/00004872-200206000-00020
   PubMed Web of Science ®Google Scholar
• Hermida RC, Crespo JJ, Domínguez-Sardiña M; for the Hygia Chronotherapy Trial investigators. 2020b. Improved reduction of cardiovascular risk by bedtime ingestion of ARB and ACEI medication class therapies. Eur Heart J 41:1602–1603. doi:10.1093/eurheratj/ehaa214
   PubMed Web of Science ®Google Scholar
• Hermida RC, Crespo JJ, Domínguez-Sardiña M, Otero A, Moyá A, Ríos MT, Sineiro E, Castiñeira MC, Callejas PA, Pousa L, et al. 2020a. Bedtime hypertension treatment improves cardiovascular risk reduction: the Hygia Chronotherapy Trial. Eur Heart J. 41:4565–4576. doi:10.1093/eurheartj/ehz754
   PubMed Web of Science ®Google Scholar
• Hermida RC, Crespo JJ, Otero A, Domínguez-Sardiña M, Moyá A, Ríos MT, Castiñeira MC, Callejas PA, Pousa L, Sineiro E, et al. 2018. Asleep blood pressure: significant prognostic marker of vascular risk and therapeutic target for prevention. Eur Heart J. 39:4159–4171. doi:10.1093/eurheartj/ehy475
   PubMed Web of Science ®Google Scholar
• Hermida RC, Hermida-Ayala RG, Mojón A, Smolensky MH, Fernández JR. 2021b. Systematic review and quality evaluation of published human ingestion-time trials of blood pressure-lowering medications and their combinations. Chronobiol Int. 38. doi:10.1080/07420528.2021.1931280
   PubMedGoogle Scholar
• Hermida RC, Hermida-Ayala RG, Smolensky MH, Mojón A, Crespo JJ, Otero A, Ríos MT, Domínguez-Sardiña M, Fernández JR. 2020c. Does timing of antihypertensive medication dosing matter? Curr Cardiol Rep. 22(118). doi:10.1007/s11886-020-01353-7
   PubMedGoogle Scholar
• Hermida RC, Hermida-Ayala RG, Smolensky MH, Mojón A, Fernández JR. 2020d. Chronopharmacology of hypertension medications: impact of ingestion-time on pharmacokinetics and pharmacodynamics. Exp Opin Drug Metab Toxicol. 16:1159–1173. doi:10.1080/17425255.2020.1825681
   PubMed Web of Science ®Google Scholar
• Hermida RC, Hermida-Ayala RG, Smolensky MH, Mojón A, Fernández JR. 2021a. Ingestion-time differences in the pharmacodynamics of hypertension medications: systematic review of human chronopharmacology trials. Adv Drug Deliv Rev. 170:200–213. doi:10.1016/j.addr.2021.01.013
   PubMed Web of Science ®Google Scholar
• Hermida RC, Mojón A, Fernández JR, Otero A, Crespo JJ, Domínguez-Sardiña M, Ríos MT, Smolensky MH. 2020e. Ambulatory blood pressure monitoring-based definition of true arterial hypertension. Minerva Med. 111:573–588. doi:10.23736/S0026-4806.20.06834-2
   PubMed Web of Science ®Google Scholar
• Hermida RC, Mojón A, Hermida-Ayala RG, Smolensky MH, Fernández JR. 2021c. Extent of asleep blood pressure reduction by hypertension medications is ingestion-time dependent: systematic review and meta-analysis of published human trials. Sleep Med Rev. doi:10.1016/j.smrv.2021.101454
   PubMedGoogle Scholar
• Hermida RC, Smolensky MH, Ayala DE, Portaluppi F, Crespo JJ, Fabbian F, Haus E, Manfredini R, Mojón A, Moyá A, et al. 2013c. 2013 ambulatory blood pressure monitoring recommendations for the diagnosis of adult hypertension, assessment of cardiovascular and other hypertension-associated risk, and attainment of therapeutic goals. Joint recommendations from the International Society for Chronobiology (ISC), American Association of Medical Chronobiology and Chronotherapeutics (AAMCC), Spanish Society of Applied Chronobiology, Chronotherapy, and Vascular Risk (SECAC), Spanish Society of Atherosclerosis (SEA), and Romanian Society of Internal Medicine (RSIM). Chronobiol Int. 30:355–410. doi:10.3109/07420528.2013.750490
   PubMed Web of Science ®Google Scholar
• Hermida RC, Smolensky MH, Balan H, Castriotta RJ, Crespo JJ, Dagan Y, El-Toukhy S, Fernández JR, FitzGerald GA, Fujimura A, et al. 2021d. Guidelines for the design and conduct of human clinical trials on ingestion-time differences – chronopharmacology and chronotherapy – of hypertension medications. Chronobiol Int. 38:1–26. doi:10.1080/07420528.2020.1850468
   PubMed Web of Science ®Google Scholar
• Hermida RC, Smolensky MH, Mojón A, Crespo JJ, Ríos MT, Domínguez-Sardiña M, Otero A, Fernández JR. 2020f. New perspectives on the definition, diagnosis, and treatment of true arterial hypertension. Expert Opin Pharmacother. 21:1167–1178. doi:10.1080/14656566.2020.1746274
   PubMed Web of Science ®Google Scholar
• Ingelsson E, Bjorklund-Bodegard K, Lind L, Arnlov J, Sundstrom J. 2006. Diurnal blood pressure pattern and risk of congestive heart failure. JAMA. 295:2859–2866. doi:10.1001/jama.295.24.2859
   PubMed Web of Science ®Google Scholar
• Jacobs L, Efremov L, Ferreira JP, Thijs L, Yang WY, Zhang ZY, Latini R, Masson S, Agabiti N, Sever P, et al. 2017. Risk for incident heart failure: a subject-level meta-analysis from the Heart “OMics” in AGEing (HOMAGE) Study. J Am Heart Assoc 6:e005231. doi:10.1161/JAHA.116.005231
   PubMed Web of Science ®Google Scholar
• Jamieson MJ, Jamieson C. 2001. Ambulatory blood pressure in heart failure. Eur J Clin Invest. 31(Suppl 2):18–25. doi:10.1046/j.1365-2362.2001.0310s2018x
   PubMedGoogle Scholar
• Kario K, Hoshide S, Mizuno H, Kabutoya T, Nishizawa M, Yoshida T, Abe H, Katsuya T, Fujita Y, Okazaki O, et al. 2020. Nighttime blood pressure phenotype and cardiovascular prognosis. Practicioner-Based Nationwide JAMP Study. Circulation 142:1810–1820. doi:10.1161/CIRCULATIONAHA.120.049730
   PubMed Web of Science ®Google Scholar
• Kastrup J, Wroblewski H, Sindrup J, Rolighed Christensen H, Wiinberg N. 1993. Diurnal blood pressure profile in patients with severe congestion heart failure: dippers and non-dippers. Scand J Clin Lab Invest. 53:577–583. PMID: 8266003.
   PubMed Web of Science ®Google Scholar
• Komori T, Eguchi K, Saito T, Hoshide S, Kario K. 2016. Riser pattern: another determinant of heart failure with preserved ejection fraction. J Clin Hypertens (Greenwich). 18:994–999. doi:10.1111/jch.12818
   PubMed Web of Science ®Google Scholar
• Komori T, Eguchi K, Saito T, Hoshide S, Kario K. 2017. Riser pattern is a novel predictor of adverse events in heart failure patients with preserved ejection fraction. Circ J. 81:220–226. doi:10.1253/circj.CJ-16-0740
   PubMed Web of Science ®Google Scholar
• Labrecque G, Beauchamp D. 2003. Rhythms and pharmacokinetics. In: Redfern P, editor. Chronotherapeutics. London: Pharmaceutical Press; p. 75–110.
   Google Scholar
• Law MR, Morris JK, Wald NJ. 2009. Use of blood pressure lowering drugs in the prevention of cardiovascular disease: meta-analysis of 147 randomised trials in the context of expectations from prospective epidemiological studies. BMJ. 338:b1665. doi:10.1136/bmj.b1665
   PubMed Web of Science ®Google Scholar
• Levy D, Larson MG, Vasan RS, Kannel WB, Ho KKL. 1996. The progression from hypertension to congestive heart failure. JAMA. 275:1557–1562. doi:10.1001/jama.1996.03530440037034
   PubMed Web of Science ®Google Scholar
• Liu L, Wang JG, Gong L, Liu G, Staessen JA. 1998. Comparison of active treatment and placebo in older Chinese patients with isolated systolic hypertension. Systolic Hypertension in China (Syst-China) Collaborative Group. J Hypertens 16:1823–1829. doi:10.1097/00004872-199816120-00016
   PubMed Web of Science ®Google Scholar
• Martino TA, Tata N, Simpson JA, Vanderlaan R, Dawood F, Kabir MG, Khaper N, Cifelli C, Podobed P, Liu PP, et al. 2011. The primary benefits of angiotensin-converting enzyme inhibition on cardiac remodeling occur during sleep time in murine pressure overload hypertrophy. J Am Coll Cardiol. 57:2020–2028. doi:10.1016/j.jacc.2010.11.022
   PubMed Web of Science ®Google Scholar
• Minutolo R, Agarwal R, Borrelli S, Chiodini P, Bellizzi V, Nappi F, Cianciaruso B, Zamboni P, Conte G, Gabbai FB, et al. 2011. Prognostic role of ambulatory blood pressure measurement in patients with nondialysis chronic kidney disease. Arch Intern Med. 171:1090–1098. doi:10.1001/archinternmed.2011.230
   PubMed Web of Science ®Google Scholar
• Mojón A, Ayala DE, Piñeiro L, Otero A, Crespo JJ, Moyá A, Bóveda J, Pérez De Lis J, Fernández JR, Hermida RC; on behalf of the Hygia Project Investigators. 2013. Comparison of ambulatory blood pressure parameters of hypertensive patients with and without chronic kidney disease. Chronobiol Int. 30:145–158. doi:10.3109/07420528.2012.703083
   PubMed Web of Science ®Google Scholar
• Moroni C, De Biase L, Pannarale G, Bondanini F, Affricano D, Campa PP, Cassone R. 1998. Blood pressure circadian rhythm and variability in subjects with severe heart failure. Blood Press. 7:282–285. doi:10.1080/080370598437132
   PubMedGoogle Scholar
• National Institute for Health and Clinical Excellence. 2019. Hypertension in adults: diagnosis and management. NICE Guideline 136: methods, evidence and recommendations. London, UK: National Clinical Guidelines Centre. accessed 23 December 2020). https://www.nice.org.uk/guidance/ng136
   Google Scholar
• Ohkubo T, Hozawa A, Yamaguchi J, Kikuya M, Ohmori K, Michimata M, Matsubara M, Hashimoto J, Hoshi H, Araki T, et al. 2002. Prognostic significance of the nocturnal decline in blood pressure in individuals with and without high 24-h blood pressure: the Ohasama study. J Hypertens. 20:2183–2189. doi:10.1097/00004872-200211000-00017
   PubMed Web of Science ®Google Scholar
• Pierdomenico SD, Pierdomenico AM, Coccina F, Lapenna D, Porreca E. 2016. Ambulatory blood pressure parameters and heart failure with reduced or preserved ejection fraction in elderly treated hypertensive patients. Am J Hypertens. 29:1001–1007. doi:10.1093/ajh/hpw015
   PubMed Web of Science ®Google Scholar
• Piper MA, Evans CV, Burda BU, Margolis KL, O’Connor E, Whitlock EP. 2015. Diagnosis and predictive accuracy of blood pressure screening methods with consideration of rescreening intervals: a systematic review for the U.S. Preventive Services Task Force. Ann Intern Med 162:192–204. doi:10.7326/M14-1539
   PubMed Web of Science ®Google Scholar
• Portaluppi F, Montanan L, Fernini M, Vergnani L, D’Ambrosi A, Cavallini AR, Bagni B, Degli Uberti E. 1991. Consistent changes in the circadian rhythms of blood pressure and atrial natriuretic peptide in congestive heart failure. Chronobiol Int 8:432–439. doi:10.3109/07420529109059178
   PubMed Web of Science ®Google Scholar
• Portaluppi F, Tiseo R, Smolensky MH, Hermida RC, Ayala DE, Fabbian F. 2012. Circadian rhythms and cardiovascular health. Sleep Med Rev. 16:151–166. doi:10.1016/j.smrv.2011.04.003
   PubMed Web of Science ®Google Scholar
• Rabi DM, McBrien KA, Sapir-Pichhadze R, Nakhla M, Ahmed SB, Dumanski SM, Butalia S, Leung AA, Harris KC, Cloutier L, et al. 2020. Hypertension Canada’s 2020 comprehensive guidelines for the prevention, diagnosis, risk assessment, and treatment of hypertension in adults and children. Can J Cardiol. 36:596–624. doi:10.1016/j.cjca.2020.02.086
   PubMed Web of Science ®Google Scholar
• Reinberg A, Smolensky MH. 1982. Circadian changes of drug disposition in man. Clin Pharmacokin. 7:401–420. doi:10.2165/00003088-198207050-00002
   PubMed Web of Science ®Google Scholar
• Ríos MT, Domínguez-Sardiña M, Ayala DE, Gomara S, Sineiro E, Pousa L, Callejas PA, Fontao MJ, Fernández JR, Hermida RC; on behalf of the Hygia Project Investigators. 2013. Prevalence and clinical characteristics of isolated-office and true resistant hypertension determined by ambulatory blood pressure monitoring. Chronobiol Int. 30:207–220. doi:10.3109/07420528.2012.701135
   PubMed Web of Science ®Google Scholar
• Roger VL. 2013. Epidemiology of heart failure. Circ Res. 113:646–659. doi:10.1161/CIRCRESAHA.113.300268
   PubMed Web of Science ®Google Scholar
• Roush GC, Fagard RH, Salles GF, Pierdomenico SD, Reboldi G, Verdecchia P, Eguchi K, Kario K, Hoshide S, Polonia J, et al. 2014a. Prognostic impact from clinic, daytime, and nighttime systolic blood pressure in 9 cohorts on 13,844 patients with hypertension. J Hypertens. 32:2332–2340. doi:10.1097/HJH.0000000000000355
   PubMed Web of Science ®Google Scholar
• Roush GC, Fapohunda J, Kostis JB. 2014b. Evening dosing of antihypertensive therapy to reduce cardiovascular events: a third type of evidence based on a systematic review and meta-analysis of randomized trials. J Clin Hypertens (Greenwich). 16:561–568. doi:10.1111/jch.12354
   PubMed Web of Science ®Google Scholar
• Salles GF, Reboldi G, Fagard RH, Cardoso C, Pierdomenico SD, Verdecchia P, Eguchi K, Kario K, Hoshide S, Polonia J, et al. 2016. Prognostic impact of the nocturnal blood pressure fall in hypertensive patients: the ambulatory blood pressure collaboration in patients with hypertension (ABC-H) meta-analysis. Hypertension. 67:693–700. doi:10.1161/HYPERTENSIONAHA.115.06981
   PubMed Web of Science ®Google Scholar
• Schillaci G, Battista F, Settimi L, Schillaci L, Pucci G. 2015. Antihypertensive drug treatment and circadian blood pressure rhythm: a review of the role of chronotherapy in hypertension. Curr Pharm Des. 21:756–772. doi:10.2174/1381612820666141024130013
   PubMed Web of Science ®Google Scholar
• Seferovic PM, Vardas P, Jankowska EA, Maggioni AP, Timmis A, Milinkovic I, Polovina M, Gale CP, Lund LH, Lopatin Y, et al. 2021. The Heart Failure Association Atlas: heart Failure Epidemiology and Management Statistics. Eur J Heart Fail. doi:10.1002/ejhf.2143
   Web of Science ®Google Scholar
• Slivnick J, Lampert BC. 2019. Hypertension and heart failure. Heart Fail Clin. 15:531–541. doi:10.1016/j.hfc.2019.06.007
   PubMed Web of Science ®Google Scholar
• Smolensky MH, Hermida RC, Ayala DE, Tiseo R, Portaluppi F. 2010. Administration-time-dependent effects of antihypertensive medications: basis for the chronotherapy of hypertension. Blood Press Monit. 15(4):173–180. doi:10.1097/MBP.0b013e32833c7308
   PubMed Web of Science ®Google Scholar
• Smolensky MH, Hermida RC, Castriotta RJ, Portaluppi F. 2007. Role of sleep-wake cycle on blood pressure circadian rhythms and hypertension. Sleep Med. 8:668–680. doi:10.1016/j.sleep.2006.11.011
   PubMed Web of Science ®Google Scholar
• Smolensky MH, Hermida RC, Geng YJ. 2021. Chronotherapy of cardiac and vascular disease: timing medications to circadian rhythms to optimize treatment effects and outcomes. Curr Opin Pharmacol. 57:41–48. doi:10.1016//j.coph.2020.10.014
   PubMed Web of Science ®Google Scholar
• Smolensky MH, Hermida RC, Portaluppi F. 2017. Circadian mechanisms of 24-hour blood pressure regulation and patterning. Sleep Med Rev. 33:4–16. doi:10.1016/j.smrv.2016.02.003
   PubMed Web of Science ®Google Scholar
• Smolensky MH, Peppas NA. 2007. Chronoibiology, drug delivery, and chronotherapeutics. Adv Drug Deliv Rev. 59:828–851. doi:10.1016/j.addr.2007.07.001
   PubMed Web of Science ®Google Scholar
• Sobiczewski W, Wirthwein M, Gruchala M, Kocic I. 2014. Mortality in hypertensive patients with coronary heart disease depends on chronopharmacotherapy and dipping status. Pharmacol Rep. 66:448–452. doi:10.1016/j.pharep.2013.12.009
   PubMed Web of Science ®Google Scholar
• Sole MJ, Martino TA. 2009. Diurnal physiology: core principles with application to the pathogenesis, diagnosis, prevention, and treatment of myocardial hypertrophy and failure. J Appl Physiol. 107:1318–1327. doi:10.1152/japplphysiol.00426.2009
   PubMed Web of Science ®Google Scholar
• Staessen JA, Fagard R, Thijs L, Celis H, Arabidze GG, Birkenhager WH, Bulpitt CJ, De Leeuw PW, Dollery CT, Fletcher AE, et al. 1997. Randomised double-blind comparison of placebo and active treatment for older patients with isolated systolic hypertension. Lancet. 350:757–764. doi:10.1016/s0140-6736(97)05381-6
   PubMed Web of Science ®Google Scholar
• Stranges PM, Drew AM, Rafferty P, Shuster JE, Brooks AD. 2015. Treatment of hypertension with chronotherapy: is it time? Ann Pharmacother. 49:323–334. doi:10.1177/1060028014563535
   PubMed Web of Science ®Google Scholar
• Svensson P, De Faire U, Sleight P, Yusuf S, Östergren J. 2001. Comparative effects of ramipril on ambulatory and office blood pressures. A HOPE substudy. Hypertension 38:e28–e32. doi:10.1161/hy1101.099502
   PubMed Web of Science ®Google Scholar
• Tatti P, Pahor M, Byington RP, Di Mauro P, Guarisco R, Strollo G, Strollo F. 1998. Outcome results of the fosinopril versus amlodipine cardiovascular events randomized trial (FACET) in patients with hypertension and NIDDM. Diabetes Care. 21:597–603. doi:10.2337/diacare.21.4.597
   PubMed Web of Science ®Google Scholar
• Tsao CW, Lyass A, Enserro D, Larson MG, Ho JE, Kizer JR, Gottdiener JS, Psaty BM, Vasan RS. 2018. Temporal trends in the incidence of and mortality associated with heart failure with preserved and reduced ejection fraction. JACC Heart Fail. 6:678–685. doi:10.1016/j.chf.2018.03.006
   PubMed Web of Science ®Google Scholar
• Ueda T, Kawakami R, Nakada Y, Nakano T, Nakagawa H, Matsui M, Nishida T, Onoue K, Soeda T, Okayama S, et al. 2019. Differences in blood pressure riser pattern in patients with acute heart failure with reduced mid-range and preserved ejection fraction. ESC Heart Fail. 6:1057–1067. doi:10.1002/ehf2.12500
   PubMed Web of Science ®Google Scholar
• Umemura S, Arima H, Arima S, Asayama K, Dohi Y, Hirooka Y, Horio T, Hoshide S, Ikeda S, Ishimitsu T, et al. 2019. The Japanese Society of Hypertension Guidelines for the Management of Hypertension (JSH 2019). Hypertens Res. 42:1235–1481. doi:10.1038/s41440-019-0284-9
   PubMed Web of Science ®Google Scholar
• Unger T, Borghi C, Charchar F, Khan NA, Poulter NR, Prabhakaran D, Ramirez A, Schlaich M, Stergiou GS, Tomaszewski M, et al. 2020. 2020 International Society of Hypertension global hypertension practice guidelines. Hypertension. 75:1334–1357. doi:10.1161/HYPERTENSIONAHA.120.15026
   PubMed Web of Science ®Google Scholar
• Van De Borne P, Abramowicz M, Degre S, Degaute JP. 1992. Effects of chronic congestive heart failure on 24-hour blood pressure and heart rate patterns: a hemodynamic approach. Am Heart J. 123:998–1004. doi:10.1016/0002-8703(92)90710-d
   PubMed Web of Science ®Google Scholar
• Whelton PK, Carey RM, Aronow WS, Casey DE Jr, Collins KJ, Himmerfarb CD, DePalma SM, Gidding S, Jamerson KA, Jones DW, et al. 2018. 2017 ACC/AHA/AAPA/ABC/ACPM/AGS/APhA/ASH/ASPC/NMA/PCNA Guideline for the Prevention, Detection, Evaluation, and Management of High Blood Pressure in Adults: a Report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines. J Am Coll Cardiol. 71:e127–e248. doi:10.1016/j.jacc.2017.11.006
   PubMed Web of Science ®Google Scholar
• White WB, Black HR, Weber MA, Elliott WJ, Brysinski B, Fakourhi TD. 1998. Comparison of effects of controlled-onset extended-release verapamil at bedtime and nifedipine gastrointestinal therapeutic system on arising on early morning blood pressure, heart rate, and the heart rate-blood pressure product. Am J Cardiol. 81:424–431. doi:10.1016/s0002-9149(97)00935-1
   PubMed Web of Science ®Google Scholar
• Williams B, Mancia G, Spiering W, Rosei EA, Azizi M, Burnier M, Clement DL, Coca A, De Simone G, Dominiczak A, et al. 2018. 2018 ESC/ESH Guidelines for the management of arterial hypertension: the Task Force for the management of arterial hypertension of the European Society of Cardiology (ESC) and the European Society of Hypertension (ESH). Eur Heart J. 39:3021–3104. doi:10.1093/eaurheartj/ehy339
   PubMed Web of Science ®Google Scholar
• Yusuf S, Sleight P, Pogue J, Bosch J, Davies R, Dagenais G. 2000. Effects of an angiotensin-converting-enzyme inhibitor, ramipril, on cardiovascular events in high-risk patients: the Heart Outcomes Prevention Evaluation Study Investigators. N Engl J Med. 342:145–153. doi:10.1056/NEJM200001203420301
   PubMed Web of Science ®Google Scholar
• Zhao P, Xu P, Wan C, Wang Z 2011. Evening versus morning dosing regimen drug therapy for hypertension. The Cochrane Database of Systematic Reviews. 10(CD004184). doi:10.1002/14651858.CD004184.pub2
   Google Scholar